These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 22886351)

  • 1. Proton pump inhibitors: impact on glucose metabolism.
    Boj-Carceller D
    Endocrine; 2013 Feb; 43(1):22-32. PubMed ID: 22886351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The entero-insular axis: implications for human metabolism.
    Ranganath LR
    Clin Chem Lab Med; 2008; 46(1):43-56. PubMed ID: 18020966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pantoprazole may improve beta cell function and diabetes mellitus.
    Inci F; Atmaca M; Ozturk M; Yildiz S; Koceroglu R; Sekeroglu R; Ipekci SH; Kebapcilar L
    J Endocrinol Invest; 2014 May; 37(5):449-54. PubMed ID: 24682913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antidiabetic actions of endogenous and exogenous GLP-1 in type 1 diabetic patients with and without residual β-cell function.
    Kielgast U; Holst JJ; Madsbad S
    Diabetes; 2011 May; 60(5):1599-607. PubMed ID: 21441444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving glycaemic control in type 2 diabetes: Stimulate insulin secretion or provide beta-cell rest?
    van Raalte DH; Verchere CB
    Diabetes Obes Metab; 2017 Sep; 19(9):1205-1213. PubMed ID: 28295962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors.
    Neumiller JJ
    J Am Pharm Assoc (2003); 2009; 49 Suppl 1():S16-29. PubMed ID: 19801361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats.
    Schwasinger-Schmidt T; Robbins DC; Williams SJ; Novikova L; Stehno-Bittel L
    Pharmacol Res; 2013 Oct; 76():58-66. PubMed ID: 23891763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta-cell failure in diabetes and preservation by clinical treatment.
    Wajchenberg BL
    Endocr Rev; 2007 Apr; 28(2):187-218. PubMed ID: 17353295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to fight obesity with antidiabetic drugs: targeting gut or kidney?
    Baretić M; Troskot R
    Minerva Endocrinol; 2015 Mar; 40(1):71-83. PubMed ID: 25366984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Automated recognition and quantification of pancreatic islets in Zucker diabetic fatty rats treated with exendin-4.
    Kakimoto T; Kimata H; Iwasaki S; Fukunari A; Utsumi H
    J Endocrinol; 2013 Jan; 216(1):13-20. PubMed ID: 23092878
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical efficacy of vitamin D in ameliorating endocrine and metabolic disorders in diabetic rats.
    Sadek KM; Shaheen H
    Pharm Biol; 2014 May; 52(5):591-6. PubMed ID: 24251869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects on pancreatic Beta and other Islet cells of the glucose-dependent insulinotropic polypeptide.
    Khan R; Tomas A; Rutter GA
    Peptides; 2020 Mar; 125():170201. PubMed ID: 31751656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapy with proton pump inhibitors in patients with type 2 diabetes is independently associated with improved glycometabolic control.
    Barchetta I; Guglielmi C; Bertoccini L; Calella D; Manfrini S; Secchi C; Pozzilli P; Cavallo MG;
    Acta Diabetol; 2015 Oct; 52(5):873-80. PubMed ID: 25716766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of single-dose DPP-4 inhibitor sitagliptin on β-cell function and incretin hormone secretion after meal ingestion in healthy volunteers and drug-naïve, well-controlled type 2 diabetes subjects.
    Alsalim W; Göransson O; Carr RD; Bizzotto R; Tura A; Pacini G; Mari A; Ahrén B
    Diabetes Obes Metab; 2018 Apr; 20(4):1080-1085. PubMed ID: 29227575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improved glucose regulation in type 2 diabetic patients with DPP-4 inhibitors: focus on alpha and beta cell function and lipid metabolism.
    Ahrén B; Foley JE
    Diabetologia; 2016 May; 59(5):907-17. PubMed ID: 26894277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal actions of glucagon-like peptide-1-based therapies: glycaemic control beyond the pancreas.
    Smits MM; Tonneijck L; Muskiet MH; Kramer MH; Cahen DL; van Raalte DH
    Diabetes Obes Metab; 2016 Mar; 18(3):224-35. PubMed ID: 26500045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigational treatments for Type 2 diabetes mellitus: exenatide and liraglutide.
    González C; Beruto V; Keller G; Santoro S; Di Girolamo G
    Expert Opin Investig Drugs; 2006 Aug; 15(8):887-95. PubMed ID: 16859392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreatic β-Cells Express the Fetal Islet Hormone Gastrin in Rodent and Human Diabetes.
    Dahan T; Ziv O; Horwitz E; Zemmour H; Lavi J; Swisa A; Leibowitz G; Ashcroft FM; In't Veld P; Glaser B; Dor Y
    Diabetes; 2017 Feb; 66(2):426-436. PubMed ID: 27864307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fasting serum total bile acid levels are associated with insulin sensitivity, islet β-cell function and glucagon levels in response to glucose challenge in patients with type 2 diabetes.
    Wang XH; Xu F; Cheng M; Wang X; Zhang DM; Zhao LH; Cai HL; Huang HY; Chen T; Zhang XL; Wang XQ; Cheng XB; Su JB; Lu Y
    Endocr J; 2020 Nov; 67(11):1107-1117. PubMed ID: 32684527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with a proton pump inhibitor improves glycaemic control in Psammomys obesus, a model of type 2 diabetes.
    Bödvarsdóttir TB; Hove KD; Gotfredsen CF; Pridal L; Vaag A; Karlsen AE; Petersen JS
    Diabetologia; 2010 Oct; 53(10):2220-3. PubMed ID: 20585936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.